Ayala Pharmaceuticals Inc (AYLA)
US Market

Ayala Pharmaceuticals (AYLA) Financial Statements


Ayala Pharmaceuticals Financial Overview

Ayala Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Ayala Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 91.00K$ 38.00K$ 458.00K$ 1.15M$ 625.00K
Gross Profit$ 0.00$ 0.00$ 90.00K$ 0.00$ 0.00
EBIT$ -10.08M$ -7.84M$ -9.85M$ -9.77M$ -9.57M
EBITDA$ -10.04M$ -7.79M$ -9.82M$ -9.74M$ -9.52M
Net Income Common Stockholders$ -10.19M$ -8.21M$ -10.03M$ -10.05M$ -9.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.20M$ 20.06M$ 27.05M$ 36.98M$ 40.84M
Total Assets$ 14.26M$ 24.02M$ 30.65M$ 41.13M$ 45.74M
Total Debt$ 396.00K$ 414.00K$ 472.00K$ 497.00K$ 493.00K
Net Debt$ -10.80M$ -19.64M$ -26.58M$ -36.48M$ -40.35M
Total Liabilities$ 6.10M$ 6.66M$ 5.83M$ 6.97M$ 6.36M
Stockholders Equity$ 8.16M$ 17.36M$ 24.82M$ 34.16M$ 39.38M
Cash Flow-
Free Cash Flow$ -9.34M$ -7.02M$ -9.98M$ -7.79M$ -9.37M
Operating Cash Flow$ -9.34M$ -7.02M$ -9.98M$ -7.79M$ -9.37M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ -2.00K
Financing Cash Flow$ 468.00K$ 0.00$ 44.00K$ 3.95M$ 5.80M
Currency in USD

Ayala Pharmaceuticals Earnings and Revenue History

Ayala Pharmaceuticals Debt to Assets

Ayala Pharmaceuticals Cash Flow

Ayala Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis